Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study
Br J Dermatol
.
2024 Apr 17;190(5):775-777.
doi: 10.1093/bjd/ljae057.
Authors
Samar B Hasan
1
,
Janine Bates
2
,
Rebecca Cannings-John
2
,
Fiona Collier
3
,
Judith Evans
2
,
Angela Gibbons
4
,
Ceri Harris
4
,
Laura Howells
5
,
Kerenza Hood
2
,
Rachel Howes
6
,
Paul Leighton
5
,
Muhammad Riaz
2
,
Jeremy Rodrigues
7
8
,
Helen Stanton
2
,
Kim S Thomas
5
,
Emma Thomas-Jones
5
,
John R Ingram
1
Affiliations
1
Division of Infection & Immunity.
2
Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.
3
NHS Forth Valley, Scotland, UK.
4
Public contributors.
5
Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
6
Department of Plastic Surgery, John Radcliffe Hospital, Oxford NHS Trust, Oxford, UK.
7
Department of Plastic Surgery, Stoke Mandeville Hospital, Buckinghamshire Healthcare Trust, Aylesbury, UK.
8
Warwick Clinical Trials Unit, University of Warwick, Warwick, UK.
PMID:
38365908
DOI:
10.1093/bjd/ljae057
No abstract available
MeSH terms
Feasibility Studies
Hidradenitis Suppurativa* / drug therapy
Humans
Pain Measurement
Quality of Life
Text Messaging*
Grants and funding
THESEUS
National Institute for Health and Care Research
17/98/01/Health Technology Assessment
Department of Health and Social Care